Digirad Corp. (NASDAQ:DRAD) rose 4% on Tuesday . The company traded as high as $5.26 and last traded at $5.23, with a volume of 62,816 shares traded. The stock had previously closed at $5.03.

DRAD has been the topic of a number of analyst reports. B. Riley restated a “buy” rating and issued a $7.00 target price on shares of Digirad Corp. in a report on Tuesday, April 26th. Zacks Investment Research upgraded shares of Digirad Corp. from a “hold” rating to a “buy” rating and set a $6.00 target price on the stock in a report on Tuesday, May 3rd. Finally, Sidoti initiated coverage on shares of Digirad Corp. in a report on Wednesday, May 25th. They issued a “buy” rating and a $8.00 target price on the stock.

The stock has a 50 day moving average price of $5.43 and a 200 day moving average price of $5.22. The stock has a market capitalization of $103.32 million and a price-to-earnings ratio of 3.24.

Digirad Corp. (NASDAQ:DRAD) last announced its quarterly earnings results on Thursday, July 28th. The company reported $0.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.09. On average, analysts predict that Digirad Corp. will post $0.31 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, August 29th. Shareholders of record on Wednesday, August 17th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 3.79%. The ex-dividend date is Monday, August 15th.

In related news, Director Jeffrey E. Eberwein bought 6,700 shares of the business’s stock in a transaction dated Friday, May 27th. The shares were purchased at an average price of $5.00 per share, with a total value of $33,500.00. Following the purchase, the director now owns 100,000 shares of the company’s stock, valued at approximately $500,000. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jeffrey E. Eberwein bought 28,482 shares of the business’s stock in a transaction dated Friday, August 19th. The shares were bought at an average cost of $5.00 per share, for a total transaction of $142,410.00. Following the purchase, the director now directly owns 12,500 shares in the company, valued at approximately $62,500. The disclosure for this purchase can be found here.

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.